Search

NeoGenomics Inc

Aperta

SettoreSettore sanitario

16.79 1.33

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

16.34

Massimo

17.07

Metriche Chiave

By Trading Economics

Entrata

19M

2.2M

Vendite

15M

202M

EPS

-0.01

Margine di Profitto

1.11

Dipendenti

2,500

EBITDA

19M

19M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+30.94% upside

Dividendi

By Acuity

Utili prossimi

28 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

370M

2.1B

Apertura precedente

15.46

Chiusura precedente

16.79

NeoGenomics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

16 ott 2026, 20:02 UTC

Correlated Moves

Neogenomics Inc shares are declining amid a broader market trend, influenced by the sharply lower ARK Genomic Revolution ETF (ARKG) and negative news at Tempus AI.

15 ott 2026, 19:46 UTC

News

NeoGenomics expands partnership with Indica Labs to enhance digital pathology using AI-driven tools, aiming to streamline operations and improve diagnostic capabilities.

14 ott 2026, 20:21 UTC

Neogenomics Inc shares are trading lower in after-market hours, tracking significant declines in major U.S. stock indices amid rising inflation concerns and expectations of a rate hike.

13 ott 2026, 20:02 UTC

Neogenomics Inc is trading higher, having rebounded from earlier weakness, after reaching a notable peak around mid-afternoon on Tuesday.

8 ott 2026, 20:07 UTC

Neogenomics Inc shares are trading modestly higher, recovering from an early drop amid a broader market gain since Wednesday's close.

7 ott 2026, 20:07 UTC

Neogenomics Inc. shares fell sharply, closing well below the 20-day moving average amid overall market declines during Wednesday's trading session.

6 ott 2026, 23:31 UTC

Neogenomics Inc saw a notable increase in after-market trading, moving higher since Tuesday's close, despite being below its 20-day moving average.

5 ott 2026, 23:01 UTC

News

NeoGenomics shares declined in after-market trading following the announcement of a leadership transition and preliminary Q3 revenue expectations of approximately $209 million.

2 ott 2026, 20:07 UTC

Neogenomics Inc is advancing, reflecting a broader market trend with significant gains today, and is higher since Thursday's close.

1 ott 2026, 20:07 UTC

Neogenomics Inc shares fell sharply, closing at their lowest point of the day and marking five consecutive lower daily closes amid ongoing market weakness.

30 set 2026, 20:31 UTC

Neogenomics Inc shares are higher in after-market trading, reversing four sessions of losses, following positive U.S. GDP growth and strong ADP employment data.

29 set 2026, 20:07 UTC

Neogenomics Inc shares fell sharply, closing near their lowest point of the day after reversing from an early peak, amid ongoing challenges.

28 set 2026, 23:11 UTC

Neogenomics Inc. saw a modest increase in after-market trading, reaching its highest cumulative return since Monday and remaining above its 20-day moving average.

25 set 2026, 22:25 UTC

Neogenomics Inc shares declined in after-market hours following Friday's close, amid broader market weakness due to flat U.S. durable goods orders and low consumer sentiment.

24 set 2026, 20:02 UTC

Neogenomics Inc is advancing sharply, maintaining a trend of higher daily closes since Wednesday, supported by strength in the broader health care services sector.

22 set 2026, 20:07 UTC

News

Neogenomics Inc shares fell sharply, declining since Monday's close, despite early session gains and interest in its strategic shift towards precision oncology.

21 set 2026, 21:21 UTC

Neogenomics Inc is trading modestly lower in after-market hours, declining from an initial high despite being above its 20-day moving average.

17 set 2026, 20:07 UTC

Correlated Moves

Neogenomics Inc is advancing, supported by gains in the ARK Genomic Revolution ETF and positive broader market trends, marking five consecutive sessions of gains.

15 set 2026, 20:07 UTC

Neogenomics Inc's shares are higher today, reflecting a notable increase since Monday's close. The stock remains above its 20-day moving average.

14 set 2026, 23:46 UTC

Neogenomics Inc shares are modestly higher in after-market trading, maintaining a position above its 20-day moving average and near the top of its one-month range.

11 set 2026, 21:01 UTC

Neogenomics Inc shares declined in after-market trading, coinciding with a significant drop in the Michigan Consumer Sentiment Index. No specific company news was identified.

10 set 2026, 20:07 UTC

Neogenomics Inc shares are lower today amid a broader market decline and rising Treasury yields, with no specific company news identified.

9 set 2026, 20:07 UTC

Neogenomics Inc's shares are higher Wednesday, despite an earlier pullback. No specific company news was identified to explain the price movement.

8 set 2026, 19:26 UTC

Neogenomics Inc shares are higher today, continuing gains since Friday. The stock remains above its 20-day moving average and within its one-month range.

4 set 2026, 23:20 UTC

Neogenomics Inc shares are higher in after-market trading, reflecting strong performance since Friday's close and positioning above its 20-day moving average.

2 set 2026, 20:08 UTC

Neogenomics Inc is lower in Wednesday's session, continuing a trend of four consecutive declines. No specific news was identified to explain the move.

1 set 2026, 20:08 UTC

Neogenomics Inc shares are lower today, continuing a downward trend since Monday. No specific company news was identified to explain the decline.

31 ago 2026, 20:07 UTC

Social Media

Neogenomics Inc shares are lower amid rising interest rate hike expectations following recent economic commentary. Earlier, the stock rebounded from a session high.

28 ago 2026, 20:51 UTC

Neogenomics Inc's shares are higher in after-market hours, moving significantly above their 20-day moving average and near the upper end of their one-month range.

27 ago 2026, 23:01 UTC

Neogenomics Inc. shares are higher in after-market trading, reflecting notable strength following Thursday's close. The stock remains above its 20-day moving average.

Confronto tra pari

Modifica del prezzo

NeoGenomics Inc Previsione

Obiettivo di Prezzo

By TipRanks

30.94% in crescita

Previsioni per 12 mesi

Media 21.5 USD  30.94%

Alto 28 USD

Basso 19 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per NeoGenomics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

6

Acquista

2

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat